Methods
=======

We employed our newly adopted SVM method in the continuous measurement of the cortical width of the mandible on dental panoramic radiographs to identify osteoporosis. We compared the diagnostic performances between this newly developed method and our trimmed mean method in identifying women with low BMD at the lumbar spine and the femoral neck in 100 postmenopausal women (\[greater than or equal to\]50 years), of whom 60 to the training and 40 to its testing with no previous record of osteoporosis. Cortical width below the mental foramen of the mandible on dental panoramic radiographs was measured continuously with CAD system by enhancing the original image of the X-ray, determining cortical boundaries, evaluating all the distances among upper and lower boundaries and finally discriminating by radial basis function - support vector machine method.

Results and Discussion
======================

The sensitivity and specificity of the cortical measurements of the lumbar spine were 90.9% (95% confidence interval shown in parentheses) (85.3-96.5) and 83.8% (76.6-91.0), respectively and 90.0% (84.1-95.9) and 69.1% (60.1-78.6), respectively with femoral neck BMD. In addition, the sensitivity and specificity for the combination of data of both the lumbar spine and femoral neck for identifying women with low BMD were 90.6% (92.0-100) and 80.9% (71.0-86.9), respectively. We assessed that the diagnosis and classification of women using support vector machine employing the average and variance of the continuous measurements provide excellent discrimination ability in comparison with the estimation of cortical width using the trimmed mean method. Conclusion: Results showed that our newly developed CAD system with SVM method improves the overall performance of the identification of high risk group of osteoporotic patients. Overall, most promising results in terms of best overall response rate (BORR) were obtained with 10 mg/kg of ipilimumab, every 3 weeks for a total of 4 doses (induction phase) followed by maintenance period in which ipilimumab was administrated every 12 weeks (maintenance phase). This was the reason for the choice of such a schedule for the front line phase 3 study. The most common treatment-related adverse events (AEs) associated with the use of ipilimumab were immune-related and specific algorithms have been subsequently developed, showing that early recognition and correct therapeutic approach with steroid therapy make most of these AEs manageable and reversible
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